What is (NAAT) RT-PCR COVID-19 Test?
The (NAAT) RT-PCR COVID-19 Test is a molecular, in vitro diagnostic test utilizing end point reverse transcriptase polymerase chain reaction (RT-PCR) and lateral flow technologies for the qualitative, detection of the coronavirus SARS-CoV-2 viral RNA.
The four steps utilized to perform the test are lysis of the virus, reverse transcription of viral RNA to cDNA, nucleic acid amplification, and detection.
The RT-PCR COVID-19 Test has been released under FDA Emergency Use Authorization (EUA) for the detection of nucleic acid from SARS-CoV-2 (the virus responsible for COVID-19 infection), and can be used in applications that require molecular/ RT-PCR testing.
Please consult your state health department for additional information regarding specific uses (such as pre and post travel requirements).
Many travel restrictions require a RT-PRC, molecular, or NAAT test be conducted prior to arrival at the destination.
The RT-PCR COVID-19 test satisfies most travel requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase
What are the differences between Rapid Tests or Antigen Tests and other COVID-19 tests?
- You have had no fever for at least 24 hours (that is one full days of no fever without the use of medicine that reduces fevers) AND
- Other symptoms have improved (for example, when your cough or shortness of breath has improved)
- At least 10 days have passed since your symptoms first appeared.